Evidence map›Paper›PMID 37908505›Full record

ArticleFrontiers in cardiovascular medicine2023

Midterm prognosis following total correction of tetralogy of fallot in adult patients.

Zahra Khajali, Nasibeh Mohammadi, Yaser Toloueitabar, Majid Maleki, Sedigheh Saedi, Zeinab Nourouzi, Saeideh Mazloum-Zadeh, Maryam Chenaghloo, Amirhossein Jalali, Hassan Tatari and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Late presenting tetralogy of Fallot-surgical management.Indian journal of thoracic and cardiovascular surgery · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Zahra KhajaliRajaei Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Nasibeh MohammadiDepartment of Cardiology, Zanjan University of Medical Sciences, Zanjan, Iran.
Yaser ToloueitabarRajaei Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Majid MalekiRajaei Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Sedigheh SaediRajaei Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Zeinab NourouziRajaei Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Saeideh Mazloum-ZadehRajaei Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Maryam ChenaghlooCardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Amirhossein JalaliRajaei Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Hassan TatariRajaei Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Maryam AliramezanyCardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
Shaheed Rajaei Cardiovascular Medical and Research Center · IRIran University of Medical Sciences · IRKerman University of Medical Sciences · IRTabriz University of Medical Sciences · IRZanjan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tetralogy of Fallot is a common congenital heart disease characterized by cyanosis. The primary treatment approach involves corrective surgery typically performed within the first year of life to achieve complete resolution. However, certain patients may undergo surgery at an older age. This study seeks to assess the efficacy of surgery by examining the midterm outcomes of total correction of Tetralogy of Fallot when performed in older individuals. Methods: This interventional-longitudinal study focused on patients who underwent complete surgery to correct tetralogy of Fallot at an advanced age of over 15 years. All of the participants were referred to the Shahid Rajaei Heart and Vascular Center, which is a referral center for congenital heart diseases in Iran, between 2010 and 2020. The surgical procedures for these patients involved primary total correction of tetralogy of Fallot or surgery following by shunt implantation. Prior to the surgery, the necessary information was gathered from the patients' medical records. The patients were then monitored over a 5-year period, during which they received regular check-ups from cardiologist with fellowship in adult congenital heart disease. Results: A total of 94 participants were enrolled in the study, with an average age of 26.7 ± 9.6 years. Notably, the majority of the participants were male. The study reported a late mortality rate of 3.2%. Furthermore, 17 patients, constituting 18% of the cohort, underwent a secondary surgical procedure. This secondary surgery encompassed 14 cases of Pulmonary Valve Replacement (14.8%) and 3 cases of Ventricular Septal Defect repair (3.1%). Conclusion: While the optimal age for total correction of Tetralogy of Fallot is conventionally considered to be within the first year of life, this study demonstrated that surgical intervention performed at a later stage of life can yield favorable midterm prognoses. It is imperative to emphasize that individuals unable to undergo surgery at the ideal age due to a multitude of factors should not be deprived of the potential benefits associated with surgical intervention.

Indexed as

adulthoodlate mortalitypulmonary valve replacementtetralogy of fallot (TOF)tetralogy of fallot total correction (TFTC)

Identifiers

PMID37908505
PMCPMC10613674
OpenAlexW4387671297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.